ArticleOncology2020

The Impact of EGFR Mutation Status and Brain Metastasis for Non-Small Cell Lung Cancer Treated with Ramucirumab plus Docetaxel.

Naoki Furuya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.